BHAGCHEM

Bhagiradha Chemicals & Industries Balance Sheet

₹236.35-1.48%
Market cap
₹3,065 crore
P/E
111.4
P/B
4.39
ROE
2.6%
Dividend yield
0.06%

As of Mar 2022, Bhagiradha Chemicals & Industries had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings rose 2,290.44% from Mar 2023.

Bhagiradha Chemicals & Industries balance sheet

As at each financial year end, newest first. H1 = half-year.

Bhagiradha Chemicals & Industries balance sheet (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital50010.4110.4112.9712.97
Reserves8,500158174186203
Borrowings1,20050.261.6488.91235
Other liabilities3,50083.47101162187
Total liabilities13,7004475769331,120
Fixed assets6,500212286549674
Capital work in progress400100100100100
Investments2,50089.38115187224
Other assets4,300134173280336
Total assets13,7004475769331,120

Balance sheet ratios

Debt to equity
0.13

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Bhagiradha Chemicals & Industries balance sheet — frequently asked questions

What is the total debt of Bhagiradha Chemicals & Industries?

Bhagiradha Chemicals & Industries reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹50.2 crore as of Mar 2023.

What is Bhagiradha Chemicals & Industries' debt-to-equity ratio?

Based on the Mar 2022 balance sheet, Bhagiradha Chemicals & Industries' debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.

What are Bhagiradha Chemicals & Industries' total assets?

Bhagiradha Chemicals & Industries' total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.

Same Data For Peers

Trade Bhagiradha Chemicals & Industries With ATS

Track BHAGCHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.